The chemical class termed V1RH14 Activators encompasses a diverse range of compounds that can activate or modulate the V1RH14 protein, a member of the vomeronasal type 1 receptor family. These activators are not direct ligands for the receptor but instead facilitate receptor activation through various indirect mechanisms within cellular signaling pathways. The activators typically function by either increasing the intracellular concentration of second messengers such as cyclic adenosine monophosphate (cAMP), modulating protein kinase activity, or altering intracellular calcium levels. By influencing these pathways, V1RH14 activators can affect the receptor's activity. For instance, compounds that enhance adenylyl cyclase activity can raise cAMP levels, which in turn may initiate a signaling cascade that results in the activation of V1RH14. Likewise, agents that inhibit the breakdown of cAMP can also sustain elevated levels of this messenger, thereby promoting a conducive environment for receptor activation.
Additionally, activators in this class can impact the receptor indirectly by modulating the activity of G proteins, which are crucial in transducing signals from G protein-coupled receptors (GPCRs) like V1RH14. Those that activate protein kinase C (PKC) influence the phosphorylation states of proteins within the cell, which can have downstream effects on V1RH14 activity. Calcium modulators can also play a role; by increasing or buffering intracellular calcium, they can influence the receptor's signaling pathway. GPCR activity is also regulated by receptor desensitization, internalization, and recycling, processes that can be affected by the cellular concentrations of ions and second messengers. All these mechanisms, while not interacting with V1RH14 directly, have the capacity to modulate the receptor's activity through their influence on the broader signaling systems within the cell. The precise interplay between these activators and V1RH14 is complex and would necessitate detailed biochemical and physiological studies to fully elucidate their effects.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A phosphodiesterase inhibitor that increases concentrations of cAMP, which could possibly activate V1RH14 by modulating its associated signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, which may phosphorylate GPCRs or related proteins, potentially affecting the signaling pathways that could possibly activate V1RH14. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates intracellular calcium, which could possibly activate V1RH14 by modulating its related signaling pathways. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Inhibits Gi/o proteins, potentially increasing cAMP levels by preventing the inhibition of adenylyl cyclase, which could possibly activate V1RH14 signaling. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Stimulates heterotrimeric G proteins, which could possibly activate V1RH14 by activating downstream signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Acts as a calcium ionophore, increasing intracellular Ca2+ levels, which could possibly activate V1RH14 by affecting signaling pathways. | ||||||